Author

Carlotta Peticone

Observed name: C. Peticone

Institution: Orchard Therapeutics (United Kingdom)

Observed institutions: University of Toronto, Autolus (United Kingdom), Orchard Therapeutics (United Kingdom), University College London

ORCID: 0000-0001-5665-6859

Observed ORCID: 0000-0001-5665-6859

OpenAlex ID: A5028295666

CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial

2021 · Shaun Cordoba, Shimobi Onuoha, et al. · Nature Medicine · 302

PDF

Enriching leukapheresis improves T cell activation and transduction efficiency during CAR T processing

2021 · Elsa Noaks, Carlotta Peticone, et al. · Molecular Therapy — Methods & Clinical Development · 68

PDF

Single-cell transcriptome analysis of CAR T-cell products reveals subpopulations, stimulation, and exhaustion signatures

2021 · Xiaonan Wang, Carlotta Peticone, et al. · OncoImmunology · 43

PDF

A standalone perfusion platform for drug testing and target validation in micro-vessel networks

2013 · Boyang Zhang, Carlotta Peticone, et al. · Biomicrofluidics · 39

PDF

Characterisation of osteogenic and vascular responses of hMSCs to Ti-Co doped phosphate glass microspheres using a microfluidic perfusion platform

2020 · Carlotta Peticone, David De Silva Thompson, et al. · Journal of Tissue Engineering · 20

PDF

A parameterised mathematical model to elucidate osteoblast cell growth in a phosphate-glass microcarrier culture

2019 · Iva Burova, Carlotta Peticone, et al. · Journal of Tissue Engineering · 18

PDF

Assessing behaviour of osteoblastic cells in dynamic culture conditions using titanium-doped phosphate glass microcarriers

2019 · David De Silva Thompson, Carlotta Peticone, et al. · Journal of Tissue Engineering · 15

PDF

Towards modular bone tissue engineering using Ti–Co-doped phosphate glass microspheres: cytocompatibility and dynamic culture studies

2017 · Carlotta Peticone, David De Silva Thompson, et al. · Journal of Biomaterials Applications · 14

PDF

Industrial translation requirements for manufacture of stem cell–derived and tissue‐engineered products

2016 · Ivan Wall, David de Silva Thompson, et al. · Wiley eBooks · 2

Imans: a Transformative Solution for Overcoming Challenges of Solid Tumour Immunotherapy and Rejuvinating Innate Immunity, With Broad Implications for Oncology and Beyond

2025 · A. Palo, A. Rubio, et al. · Cytotherapy · 1

Breaking Free From Viruses: Developing a Scalable Non-viral Platform for Hsc Gene Therapy Using Crispr/cas9 and Sleeping Beauty Transposon Delivered Via Nucleofection or Lipid Nanoparticles

2026 · T.J. Laufer, R. Khalife, et al. · Cytotherapy

Toward the Development of an Automated Manufacturing Process for Haematopoietic Stem Cell Gene Therapies

2025 · A. Rubio Gomez, V. Paraskevas, et al. · Cytotherapy

Manufacturing of hematopoietic stem cell gene therapies: opportunities for process automation

2021 · Carlotta Peticone, Emma Chan · Cell and Gene Therapy Insights

Microscale tissue engineering: a modular approach for vascularized bone regeneration

2017 · Carlotta Peticone · UCL Discovery (University College London)

CHAPTER 5. Titanium Phosphate Glass Microspheres as Microcarriers for In Vitro Bone Cell Tissue Engineering

2014 · Nilay J. Lakhkar, Carlotta Peticone, et al. · RSC smart materials

Titanium/cobalt-Doped Phosphate Glass Microcarriers for Bone Tissue Engineering Applications

2014 · Carlotta Peticone, Jonathan C. Knowles, et al. · University of Brighton Repository (University of Brighton)

Works count: 16

Citation count: 522

H-index: 8

I10-index: 8